The contribution of genetic factors to phenotype and progression of drusen in early age-related macular degeneration

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 252, Issue 8, 2014, Pages 1273-1281

  Dietzel, Martha ^a,b   Pauleikhoff, Daniel ^b   Arning, Astrid ^a   Heimes, Britta ^b   Lommatzsch, Albrecht ^b   Stoll, Monika ^a   Hense, Hans Werner ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b ST FRANZISKUS HOSPITAL   (Germany)

Author keywords

ABCA1; ARMS2; CFH; Drusen; Early age related macular degeneration; Genetics; Phenotype

Indexed keywords

ABC TRANSPORTER A1; ARMS2 PROTEIN; COMPLEMENT FACTOR H; UNCLASSIFIED DRUG; ABCA1 PROTEIN, HUMAN; ARMS2 PROTEIN, HUMAN; COMPLEMENT FACTOR H, HUMAN; PROTEIN;

ABCA1 GENE; ADULT; AGED; AGING; ARMS2 GENE; ARTICLE; CFH GENE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DNA POLYMORPHISM; DRUSEN; FEMALE; FOLLOW UP; GENE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HEREDITY; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; CAUCASIAN; GENETICS; GENOTYPING TECHNIQUE; GERMANY; MACULAR DEGENERATION; MIDDLE AGED; PROSPECTIVE STUDY; RETINAL DRUSEN; SINGLE NUCLEOTIDE POLYMORPHISM; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ATP BINDING CASSETTE TRANSPORTER 1; COMPLEMENT FACTOR H; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPING TECHNIQUES; GERMANY; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; PROTEINS; RETINAL DRUSEN;

EID: 84908356608     PISSN: 0721832X     EISSN: 1435702X     Source Type: Journal    
DOI: 10.1007/s00417-014-2690-7     Document Type: Article

References (31)

1. van Leeuwen R, Klaver CC, Vingerling JR, Hofman A, de Jong PT (2003) Epidemiology of age-related maculopathy: a review. Eur J Epidemiol 18:845-854 (Pubitemid 37169020)
2. van Leeuwen R, Klaver CC, Vingerling JR, Hofman A, de Jong PT (2003) The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study. Arch Ophthalmol 121:519-526 (Pubitemid 36427639)
3. de Jong PT (2006) Age-related macular degeneration. N Engl J Med 355:1474-1485
4. Seddon JM, Reynolds R, Yu Y, Daly MJ, Rosner B (2011) Risk models for progression to advanced age-relatedmacular degeneration using demographic, environmental, genetic, and ocular factors. Ophthalmology 118:2203-2211
5. Seddon JM, George S, Rosner B, Rifai N (2005) Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers. Arch Ophthalmol 123:774-782 (Pubitemid 41056598)
6. Yu Y, Reynolds R, Rosner B, Daly MJ, Seddon JM (2012) Prospective assessment of genetic effects on progression to different stages of age-related macular degeneration using multistate Markov models. Invest Ophthalmol Vis Sci 53:1548-1556
7. Fritsche LG, Chen W, Schu M et al (2013) Seven new loci associated with age-related macular degeneration. Nat Genet 45:433-439
8. Grassmann F, Fritsche LG, Keilhauer CN, Heid IM, Weber BH (2012) Modelling the genetic risk in age-related macular degeneration. PLoS One 7:e37979
9. Klein R, Davis MD, Magli YL, Segal P, Klein BE, Hubbard L (1991) The Wisconsin age-related maculopathy grading system. Ophthalmology 98:1128-1134
10. Bird AC, Bressler NM, Bressler SB et al (1995) An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 39:367-374
11. van de Ven JPH, Smailhodzic D, Boon CJF et al (2012) Association analysis of genetic and environmental risk factors in the cuticular drusen subtype of age-related macular degeneration. Mol Vis 18:2271-2278
12. Holliday EG, Smith AV, Cornes BK et al (2013) Insights into the genetic architecture of early stage age-related macular degeneration: a genome-wide association study meta-analysis. PLoS One 8:e53830
13. Delcourt C, Delyfer MN, Rougier MB et al (2011) Associations of complement factor H and smoking with early age-related macular degeneration: the ALIENOR study. Invest Ophthalmol Vis Sci 52:5955-5962
14. Farwick A, Wellmann J, Stoll M, Pauleikhoff D, Hense HW (2010) Susceptibility genes and progression in age-related maculopathy: a study of single eyes. Invest Ophthalmol Vis Sci 51:731-736
15. Farwick A, Dasch B, Weber BH, Pauleikhoff D, Stoll M, Hense HW (2009) Variations in five genes and the severity of age-related macular degeneration: results from the Münster aging and retina study. Eye (Lond) 23:2238-2244
16. Magnusson KP, Duan S, Sigurdsson H et al (2005) CFH Y402H confers similar risk of soft drusen and both forms of advanced AMD. PLoS Med 3:e5
17. Yu Y, Reynolds R, Fagerness J, Rosner B, Daly MJ, Seddon JM (2011) Association of variants in the LIPC and ABCA1 genes with intermediate and large drusen and advanced age-related macular degeneration. Invest Ophthalmol Vis Sci 52:4663-4670
18. Shuler RK Jr, Schmidt S, Gallins P et al (2008) Phenotype analysis of patients with the risk variant LOC387715 (A69S) in age-related macular degeneration. Am J Ophthalmol 145:303-307
19. Francis PJ, Schultz DW, Hamon S, Ott J, Weleber RG, Klein ML (2007) Haplotypes in the complement factor H (CFH) gene: associations with drusen and advanced age-related macular degeneration. PLoS One 2:e1197
20. Tedeschi-Blok N, Buckley J, Varma R, Triche TJ, Hinton DR (2007) Population-based study of early age-related macular degeneration: role of the complement factor H Y402H polymorphism in bilateral but not unilateral disease. Ophthalmology 114:99-103 (Pubitemid 46014304)
21. Lin JM, Tsai YY, Wan L et al (2008) Complement factor H variant increases the risk for early age-related macular degeneration. Retina 28:1416-1420
22. Dasch B, Fuhs A, Schmidt J et al (2005) Serum levels of macular carotenoids in relation to age-related maculopathy The Münster Aging and Retina Study (MARS). Graefes Arch Clin Exp Ophthalmol 243:1028-1035 (Pubitemid 41631044)
23. Dasch B, Fuhs A, Behrens T et al (2005) Inflammatory markers in age-related maculopathy: cross-sectional analysis from the Münster Aging and Retina Study. Arch Ophthalmol 123:1501-1506 (Pubitemid 41626685)
24. Dietzel M, Zeimer M, Heimes B, Claes B, Pauleikhoff D, Hense HW (2011) Determinants of macular pigment optical density and its relation to age-related maculopathy: results from the Münster Aging and Retina Study (MARS). Invest Ophthalmol Vis Sci 52:3452-3457
25. Hageman GS, Anderson DH, Johnson LV et al (2005) A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A 102:7227-7232 (Pubitemid 40696361)
26. Haines JL, Hauser MA, Schmidt S et al (2005) Complement factor H variant increases the risk of age-related macular degeneration. Science 308:419-421 (Pubitemid 40530081)
27. Klein RJ, Zeiss C, Chew EY et al (2005) Complement factor H polymorphism in age-related macular degeneration. Science 308:385-389 (Pubitemid 40530070)
28. Rivera A, Fisher SA, Fritsche LG et al (2005) Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum Mol Genet 14:3227-3236 (Pubitemid 41631297)
29. Gehrs KM, Anderson DH, Johnson LV, Hageman GS (2006) Age-related macular degeneration-emerging pathogenetic and therapeutic concepts. Ann Med 38:450-471 (Pubitemid 44767496)
30. Ferris FL III, Wilkinson CP, Bird A et al (2013) Clinical classification of age-related macular degeneration. Ophthalmology 120:844-851
31. Leveziel N, Tilleul J, Puche N et al (2011) Genetic factors associated with age-related macular degeneration. Ophthalmologica 226:87-102